Q: Last 2 days Wildbrain had big volume trade and high gain. Are there any news that caused these events ?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hello 5i,
Can provide and info on this company?
Thanks
Dave
Can provide and info on this company?
Thanks
Dave
Q: Could you please comment on SPG's current balance sheet? Would you still recommend against investing here (as you did in July 2020) because of company's debt vs. cash position?
Q: Would you buy HAI at current price ? Thanks
Q: Any idea why such a big move with this company on Friday. I own a small position and could not find any news. I’m wondering whether I should add to it or should I wait?
Thanks John
Thanks John
-
Protech Home Medical Corp. (PTQ)
-
Sangoma Technologies Corporation (STC $6.81)
-
ProntoForms Corporation (PFM)
-
Strathcona Resources Ltd. (SCR $35.39)
-
Sernova Biotherapeutics Inc. (SVA $0.17)
-
Profound Medical Corp. (PRN $8.00)
-
Grande West Transportation Group Inc. (BUS)
-
Real Matters Inc. (REAL $7.27)
-
Viemed Healthcare Inc. (VMD $6.82)
-
Good Natured Products Inc. (GDNP $0.02)
-
Xebec Adsorption Inc. (XBC $0.51)
-
Nova Leap Health Corp. (NLH $0.29)
-
Vitalhub Corp. (VHI $10.87)
-
WELL Health Technologies Corp. (WELL $5.19)
-
Martello Technologies Group Inc. (MTLO $0.02)
-
Converge Technology Solutions Corp. (CTS $5.99)
-
Quisitive Technology Solutions Inc. (QUIS $0.56)
-
Skylight Health Group Inc. (SHG)
-
Lightspeed Commerce Inc. Subordinate Voting Shares (LSPD $15.46)
-
Adcore Inc. (ADCO $0.23)
-
Docebo Inc. (DCBO $37.37)
-
Greenlane Renewables Inc. (GRN $0.27)
-
Premier Health of America Inc. (PHA $0.03)
-
Repare Therapeutics Inc. (RPTX $1.80)
-
CloudMD Software & Services Inc. (DOC $0.04)
-
Palantir Technologies Inc. (PLTR $175.44)
-
Nuvei Corporation Subordinate Voting Shares (NVEI $47.61)
-
Wishpond Technologies Ltd. (WISH $0.16)
-
Mitek Systems Inc. (MITK $9.05)
Q: First of all, thanks for the service you provide. I have found it extremely useful since becoming a member. Second, I apologize for the number of stocks covered in the question. If it is too many, please do not respond / post.
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Within the last 12 months, I have purchased the above stocks strictly for growth or as momentum plays.
I would like to know which ones you would sell, either because their momentum has likely peaked, or because their share price growth prospects are poor. Please deduct as many credits as required. Thanks
Q: I know that you are not a fan of this company. Have you looked at it after there last quarter. To me it just looks like where we will do things in the future and how. Seems to do more than a Uber and a DoorDash. Could it be something in the future like when Amazon and Tesla and everybody told us not to touch them in there early days? Too much debt, no earnings, over valued, to much risk. What do you think?
Thanks Again
Thanks Again
Q: Morning 5i,
I bought FTG in mid 2017 at $4.55 as it was trending upwards, but then watched (and held on) as it slipped and slipped to a low of approximately $2.00 in early 2019. I then watched some more as it rose steadily through 2019 to peak at $4.21 in early January, 2020 - leading me to naively hope my loyalty might soon be rewarded - only to watch it crash mercilessly in Feb and March 2020. I think it had started that downward trajectory before COVID took hold and, at least initially, I don't think its decline was due to the pandemic.
I went through something similar with BUS, held on devotedly, and I'm now being rewarded as it has just recently exceeded my long ago purchase price and rightly or wrongly I think its future is rather bright.
My question - do you see any prospect for FTG to have the sort of resurgence that BUS has recently had (I know that apart from the rocky road they've both been treading over the past 3 or so years they have little in common, and also that FTG is significantly smaller) or would I be well advised to take my lumps and deploy the (now considerably less) money elsewhere.
Thanks, as always, for your thoughts and advice.
Peter
I bought FTG in mid 2017 at $4.55 as it was trending upwards, but then watched (and held on) as it slipped and slipped to a low of approximately $2.00 in early 2019. I then watched some more as it rose steadily through 2019 to peak at $4.21 in early January, 2020 - leading me to naively hope my loyalty might soon be rewarded - only to watch it crash mercilessly in Feb and March 2020. I think it had started that downward trajectory before COVID took hold and, at least initially, I don't think its decline was due to the pandemic.
I went through something similar with BUS, held on devotedly, and I'm now being rewarded as it has just recently exceeded my long ago purchase price and rightly or wrongly I think its future is rather bright.
My question - do you see any prospect for FTG to have the sort of resurgence that BUS has recently had (I know that apart from the rocky road they've both been treading over the past 3 or so years they have little in common, and also that FTG is significantly smaller) or would I be well advised to take my lumps and deploy the (now considerably less) money elsewhere.
Thanks, as always, for your thoughts and advice.
Peter
Q: I'd appreciate your views on Xphyto Therapeutics, a company based in B.C. but with important partnerships in Germany. They appear to have a couple of very promising irons in the fire, including a portable PCR test for Covid-19.
Q: Hi 5i , How speculative is Spearmint and can you see it getting any traction ? Thanks
Q: Recognizing that STC, (Sangamo Technologies) and XBC ( Xebec Adsorption) are in two entirely different fields, which of the two would you recommend for a 2/3 year hold and why.
Thanks
David
Thanks
David
Q: Your opinion please...
Q: I have 25000 shares of this co. What do you think of it?
Q: do you see any chance of a recovery for these two stocks, or best just to move on? they are in a RRSP account so no chance for tax loss.
thanks Dave
thanks Dave
Q: I already own XBC, and have been looking at GRN it has moved up a bit lately. Is it a buy? Was just wondering how much difference there was in these two companies. XBC seems to be more into the hydrogen and cleaning of gases. Is GRN more into RNG equipment and installations. I know you really like XBC and was wondering whether it would be suitable to buy GRN. Or do you have another company in the same field that might be better or should I just add to my XBC.
Thanks John
Thanks John
Q: Hello Peter, Ryan, and 5i Team,
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
I know you haven't been a big fan of these two companies in the past, due to some questionable management issues before they split from Patient Home Monitoring. However, Viemed shares have surged since listing on the Nasdaq (with some help from Covid) and PTQ has shown recent momentum with last week's announcement of a pending Nasdaq listing. Could you please give me your current thoughts on these two companies? Specifically, does the potential for a cross-listing gain with PTQ outweigh some of the other concerns, or would you still be wary? Thanks, Brad
Q: I bought a 1 percent position after your lgo comments. It is showing some nice momentum. Worth adding another percent if I am still short in materials? What is there advantage over competitors?
Thx as always
Brian
Thx as always
Brian
Q: Hi 5i,
Any thoughts on Wish?
Thanks
John
Any thoughts on Wish?
Thanks
John
Q: Please comment on the recent stock price strength and do you know anything about their business model for actually creating revenue. Are they planning to go to market directly or through licensing to much larger players in the Ag industry?
Thanks.
Thanks.
Q: What are your thoughts on RJK Explorations?